Ensysce Biosciences, Inc. (ENSC) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.5M | -1.53M | -1.87M | -2.71M | -1.71M | -764.09K | -1.02M | -2.31M | -3.41M | -1.8M | -2.26M | -3.11M | -3.61M | -3.3M | -6.71M | -4.44M | -3.44M | -3.77M | -3.82M | -383.29K |
| Operating CF Margin % | -364.3% | - | -378.46% | -197.37% | -129.35% | -58.61% | -29.84% | -1270.59% | -1114.87% | -349.86% | -519.69% | -633.79% | -456.78% | -229.91% | -2403.54% | -2140.3% | -569.89% | -230.41% | -318.53% | -86.23% |
| Operating CF Growth % | -105.04% | -99.69% | -82.9% | -17.19% | 49.91% | 57.59% | 54.91% | 25.69% | 5.5% | 45.33% | 66.3% | 30% | -4.94% | 12.53% | -75.54% | -1058.51% | -564.61% | -605.77% | -2401.38% | -49.05% |
| Net Income | -3.56M | -5.62M | -3.73M | -1.73M | -1.95M | -3.56M | 661.77K | -1.97M | -3.12M | -3.5M | -2.69M | -2.24M | -2.19M | -5.48M | -9.86M | -7.92M | -951.11K | -10.04M | -17.16M | -935.54K |
| Depreciation & Amortization | 6.53K | 0 | 0 | 0 | 0 | 0 | 0 | 25.73K | 1.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50 | 50 |
| Stock-Based Compensation | 8.74K | 249.11K | 96.58K | 156.92K | 46.09K | 30.15K | 20.82K | 26.55K | 33.21K | 628.94K | 55.67K | 77.42K | 117.13K | 216.68K | 157.15K | 295.58K | 402.43K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61.28K |
| Other Non-Cash Items | 3.09K | 3.06M | -577.21K | 94.65K | 9.28K | 17.64K | -2.34K | -5.99K | 18.25K | 331.55K | -9.62K | -43.67K | -364.06K | -783.89K | 3.55M | 846.62K | -3.19M | 8.04M | 13.09M | -42.55K |
| Working Capital Changes | 37.13K | 793.22K | 2.34M | -1.22M | 182.79K | 2.75M | -1.7M | -388.39K | -1.51M | 742K | 382.11K | -902.99K | -1.17M | 2.75M | -568.2K | 2.34M | 301.41K | -1.77M | 253.56K | 533.47K |
| Change in Receivables | 420.35K | -415.93K | 1.2M | -1.18M | 102.11K | 1.66M | 126.66K | -128K | 1.34K | 10.18K | -160 | 181.73K | -12.49K | -136.01K | 135.82K | 531.97K | -366.88K | -354.85K | -11.51K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 160 | -181.73K | -1.16M | 0 | -135.82K | -531.97K | 0 | 0 | 0 | 0 |
| Change in Payables | -1.66M | 2.71M | 0 | 427.54K | -741.78K | -521.26K | 1.74M | -499.75K | -1.3M | 793.09K | -358.21K | -323.54K | -1.35M | 1.66M | -1.76M | 2.09M | 0 | -170.75K | -1.6M | 0 |
| Cash from Investing | 0 | 0 | -123.64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.5K | 0 | 0 | 62.5K |
| Capital Expenditures | 0 | 0 | -123.64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 25.07% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | 0% | 0% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.5K | 0 | 0 | 0 |
| Cash from Financing | -63.95K | 4.16M | 1.45M | 1.87M | 1.26M | 112.58K | 4.13M | -51.23K | 5.69M | 1.46M | -102.45K | 5.52M | 1.87M | 1.94M | 7.48M | -265.81K | -391.27K | 9.19M | 2.66M | 8.17M |
| Debt Issued (Net) | 0 | 0 | -39.98K | -24.07K | -47.23K | 0 | -71.35K | -51.23K | -638.87K | 1.61M | -102.45K | -584.86K | -415.35K | -1.14M | 7.53M | -265.81K | -391.27K | 9.48M | 4.03M | 165K |
| Equity Issued (Net) | 0 | 4.66M | 0 | 2.24M | 1.45M | 357.86K | 1.67M | 0 | 6.79M | 0 | 0 | 6.36M | 2.69M | 3.78M | 0 | 0 | 0 | 0 | -1.18M | 8.07M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -290 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -63.95K | -496.39K | 1.49M | -352.85K | -142.95K | -245.28K | 2.53M | 0 | -465.2K | -144.54K | 0 | -253.84K | -398.72K | -700.45K | -51.17K | 0 | 0 | -293.12K | -195.42K | -62.5K |
| Net Change in Cash | -3.56M | 2.64M | -538.36K | -840.92K | -449.59K | -651.51K | 3.11M | -2.36M | 2.28M | -340.78K | -2.37M | 2.41M | -1.73M | -1.36M | 768.43K | -4.71M | -3.82M | 5.42M | -1.17M | 7.99M |
| Free Cash Flow | -3.5M | -1.53M | -1.99M | -2.71M | -1.71M | -764.09K | -1.02M | -2.31M | -3.41M | -1.8M | -2.26M | -3.11M | -3.61M | -3.3M | -6.71M | -4.44M | -3.44M | -3.77M | -3.82M | -383.29K |
| FCF Margin % | -364.3% | - | -403.53% | -197.37% | -129.35% | -58.61% | -29.84% | -1270.59% | -1114.87% | -349.86% | -519.69% | -633.79% | -456.78% | -229.91% | -2403.54% | -2140.3% | -569.89% | -230.41% | -318.53% | -86.23% |
| FCF Growth % | -105.04% | -99.69% | -95.02% | -17.19% | 49.91% | 57.59% | 54.91% | 25.69% | 5.5% | 45.33% | 66.3% | 30% | -4.94% | 12.53% | -75.54% | -1058.52% | -564.61% | -610.68% | -2342.45% | -49.05% |
| FCF per Share | -0.51 | -0.06 | -0.69 | -1.23 | -1.22 | -0.62 | -0.54 | -1.15 | -1.60 | -0.80 | -0.73 | -1.37 | -3.42 | -6.17 | -41.77 | -31.36 | -30.23 | -37.54 | -37.85 | -5.73 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.55x | 0.50x | 1.56x | 0.88x | 0.21x | -1.54x | 1.17x | 1.09x | 0.51x | 0.84x | 1.39x | 1.65x | 0.60x | 0.68x | 0.56x | 3.61x | 0.38x | 0.22x | 0.41x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.2K | 0 | 0 | 0 | 0 | 0 | 1.6K | 0 | 0 | 0 | 0 |